CIDEB and Wilson disease: In this assay, we observed reduced VLDL secretion in KO mice on both WD and CDA-HFD (Fig. 6H,I), which is consistent with Cideb KO mice on WD having reduced plasma cholesterol (Fig. 4E,K), an observation that is also favorable for therapeutic approaches.